Webinar: Unique Market Access Considerations for Small Biopharmas

Presented by

John D. McDermott, Jr., MBA,

Vice President

John McDermott is a vice president at Covance Market Access Services whose interests include reimbursement planning, marketing strategy development, and public policy analysis for the drug and medical device industries. In his 19 years as a consultant, he has focused on value proposition development, Medicare and managed-care payment strategies, new-product launch planning, and payer and provider market research for cardiology, gastroenterology, neurology, oncology, and urology drugs and devices.

Before joining Covance, Mr. McDermott spent two years at Hill-Rom, the world’s largest maker of hospital beds and therapeutic support surfaces, as manager of strategic planning and new business development. He gained valuable exposure to academic medicine as an intern for three years in the Dean's Office at Dartmouth Medical School. He also spent a summer as a pension fund analyst at Shearson Lehman Hutton and as a marketing intern at Amgen.

Mr. McDermott received his A.B. from Dartmouth College with honors in English and a modified major in Native American Studies. He received his M.B.A with a concentration in health services management from the Fuqua School of Business at Duke University.

John Carlsen, MHA,

Vice President

John Carlsen has more than 12 years of experience with coding, coverage, and reimbursement issues in various settings of care. Mr. Carlsen specializes in assessing the impact of changes to Medicare and managed care payment systems on the reimbursement of drugs, biologics, and devices, and has collaborated with manufacturers on multiple coding and reimbursement applications. He closely follows the latest health care policy developments and, most recently, has worked with numerous clients in the areas of health care reform, Part B vs. Part D issues, comparative effectiveness, off-label coverage, ICD-10 implementation, and Section 1847A of the Social Security Act.

Prior to joining Covance, Mr. Carlsen worked at the Ohio State University (OSU) Medical Center in Columbus, Ohio, where he focused on financial management and medical information management issues.

Mr. Carlsen received an M.H.A. from OSU’s Graduate Program in Health Services Management and Policy, and a B.A. in Economics with minors in Business and Psychology from Duke University.

Tracy Mayne, PhD,

Vice President

Dr. Tracy Mayne joined Covance Market Access Services as a Vice President leading the global Health Economics and Outcomes Research (HEOR) practice. Dr. Mayne received his Ph.D. in clinical health psychology from Rutgers University, completed his clinical training at the Psychiatry Residency Program at the University of California, San Francisco, and his research fellowship at INSERM in France.

Dr. Mayne began his professional career in public health as Director of HIV Epidemiology and Surveillance for the New York City Department of Health, with academic appointments at Columbia and New York University. From there, he spent six years at Pfizer as Economic Lead for Bextra, Celebrex, and Lipitor. Subsequently, he served as Global Renal Anemia Lead at Amgen, providing market access support for EPOGEN and Aranesp, as well as helping launch Kepivance and Vectibix. Most recently, he started the HEOR consulting practice at DaVita Clinical Research, growing the group to a multimillion-dollar business in three years.